MicroRNA Treatment Modulates Osteogenic Differentiation Potential of Mesenchymal Stem Cells Derived from Human Chorion and Placenta

Overview

Journal Sci Rep

Specialty Science

Date 2021 Apr 8

PMID 33828198

Citations 5

Authors

Kulisara Marupanthorn

Chairat Tantrawatpan

Pakpoom Kheolamai

Duangrat Tantikanlayaporn

Sirikul Manochantr

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSCs) are important in regenerative medicine because of their potential for multi-differentiation. Bone marrow, chorion and placenta have all been suggested as potential sources for clinical application. However, the osteogenic differentiation potential of MSCs derived from chorion or placenta is not very efficient. Bone morphogenetic protein-2 (BMP-2) plays an important role in bone development. Its effect on osteogenic augmentation has been addressed in several studies. Recent studies have also shown a relationship between miRNAs and osteogenesis. We hypothesized that miRNAs targeted to Runt-related transcription factor 2 (Runx-2), a major transcription factor of osteogenesis, are responsible for regulating the differentiation of MSCs into osteoblasts. This study examines the effect of BMP-2 on the osteogenic differentiation of MSCs isolated from chorion and placenta in comparison to bone marrow-derived MSCs and investigates the role of miRNAs in the osteogenic differentiation of MSCs from these sources. MSCs were isolated from human bone marrow, chorion and placenta. The osteogenic differentiation potential after BMP-2 treatment was examined using ALP staining, ALP activity assay, and osteogenic gene expression. Candidate miRNAs were selected and their expression levels during osteoblastic differentiation were examined using real-time RT-PCR. The role of these miRNAs in osteogenesis was investigated by transfection with specific miRNA inhibitors. The level of osteogenic differentiation was monitored after anti-miRNA treatment. MSCs isolated from chorion and placenta exhibited self-renewal capacity and multi-lineage differentiation potential similar to MSCs isolated from bone marrow. BMP-2 treated MSCs showed higher ALP levels and osteogenic gene expression compared to untreated MSCs. All investigated miRNAs (miR-31, miR-106a and miR148) were consistently downregulated during the process of osteogenic differentiation. After treatment with miRNA inhibitors, ALP activity and osteogenic gene expression increased over the time of osteogenic differentiation. BMP-2 has a positive effect on osteogenic differentiation of chorion- and placenta-derived MSCs. The inhibition of specific miRNAs enhanced the osteogenic differentiation capacity of various MSCs in culture and this strategy might be used to promote bone regeneration. However, further in vivo experiments are required to assess the validity of this approach.

Citing Articles

The potential link between the development of Alzheimer's disease and osteoporosis.

Nasme F, Behera J, Tyagi P, Debnath N, Falcone J, Tyagi N Biogerontology. 2025; 26(1):43.

PMID: 39832071 DOI: 10.1007/s10522-024-10181-z.

Improvement of osteogenic differentiation potential of placenta-derived mesenchymal stem cells by metformin via AMPK pathway activation.

Manochantr S, Meesuk L, Chadee N, Suwanprateeb J, Tantrawatpan C, Kheolamai P Stem Cell Res Ther. 2024; 15(1):417.

PMID: 39533406 PMC: 11559138. DOI: 10.1186/s13287-024-04014-6.

Remote Activation of Mechanotransduction via Integrin Alpha-5 via Aptamer-Conjugated Magnetic Nanoparticles Promotes Osteogenesis.

Hajiali H, Rotherham M, El Haj A Pharmaceutics. 2024; 16(1).

PMID: 38258032 PMC: 10821094. DOI: 10.3390/pharmaceutics16010021.

Fucoxanthin diminishes oxidative stress damage in human placenta-derived mesenchymal stem cells through the PI3K/Akt/Nrf-2 pathway.

Suwanmanee G, Tantrawatpan C, Kheolamai P, Paraoan L, Manochantr S Sci Rep. 2023; 13(1):22974.

PMID: 38151503 PMC: 10752906. DOI: 10.1038/s41598-023-49751-5.

Osteogenic differentiation and proliferation potentials of human bone marrow and umbilical cord-derived mesenchymal stem cells on the 3D-printed hydroxyapatite scaffolds.

Meesuk L, Suwanprateeb J, Thammarakcharoen F, Tantrawatpan C, Kheolamai P, Palang I Sci Rep. 2022; 12(1):19509.

PMID: 36376498 PMC: 9663507. DOI: 10.1038/s41598-022-24160-2.

References

Hu L, Yin C, Zhao F, Ali A, Ma J, Qian A . Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment. Int J Mol Sci. 2018; 19(2). PMC: 5855582. DOI: 10.3390/ijms19020360. View

Wang J, Liu S, Li J, Zhao S, Yi Z . Roles for miRNAs in osteogenic differentiation of bone marrow mesenchymal stem cells. Stem Cell Res Ther. 2019; 10(1):197. PMC: 6599379. DOI: 10.1186/s13287-019-1309-7. View

Li H, Li T, Wang S, Wei J, Fan J, Li J . miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res. 2013; 10(3):313-24. DOI: 10.1016/j.scr.2012.11.007. View

Nancarrow-Lei R, Mafi P, Mafi R, Khan W . A Systemic Review of Adult Mesenchymal Stem Cell Sources and their Multilineage Differentiation Potential Relevant to Musculoskeletal Tissue Repair and Regeneration. Curr Stem Cell Res Ther. 2017; 12(8):601-610. DOI: 10.2174/1574888X12666170608124303. View

Afzal F, Pratap J, Ito K, Ito Y, Stein J, van Wijnen A . Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol. 2004; 204(1):63-72. DOI: 10.1002/jcp.20258. View

Horak M, Novak J, Bienertova-Vasku J . Muscle-specific microRNAs in skeletal muscle development. Dev Biol. 2015; 410(1):1-13. DOI: 10.1016/j.ydbio.2015.12.013. View

Li Y, Jin D, Xie W, Wen L, Chen W, Xu J . Mesenchymal Stem Cells-Derived Exosomes: A Possible Therapeutic Strategy for Osteoporosis. Curr Stem Cell Res Ther. 2018; 13(5):362-368. DOI: 10.2174/1574888X13666180403163456. View

Zheng L, Tu Q, Meng S, Zhang L, Yu L, Song J . Runx2/DICER/miRNA Pathway in Regulating Osteogenesis. J Cell Physiol. 2016; 232(1):182-91. PMC: 5028245. DOI: 10.1002/jcp.25406. View

De Biase P, Capanna R . Clinical applications of BMPs. Injury. 2005; 36 Suppl 3:S43-6. DOI: 10.1016/j.injury.2005.07.034. View

10.

Tian L, Zheng F, Li Z, Wang H, Yuan H, Zhang X . miR-148a-3p regulates adipocyte and osteoblast differentiation by targeting lysine-specific demethylase 6b. Gene. 2017; 627:32-39. DOI: 10.1016/j.gene.2017.06.002. View

11.

Ryoo H, Lee M, Kim Y . Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene. 2005; 366(1):51-7. DOI: 10.1016/j.gene.2005.10.011. View

12.

Nishimura R, Hata K, Ikeda F, Ichida F, Shimoyama A, Matsubara T . Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab. 2008; 26(3):203-12. DOI: 10.1007/s00774-007-0824-2. View

13.

Ryoo H, Hoffmann H, Beumer T, Frenkel B, Towler D, Stein G . Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol. 1997; 11(11):1681-94. DOI: 10.1210/mend.11.11.0011. View

14.

Shen C, Yang C, Xu S, Zhao H . Comparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua (DC). Cell Biosci. 2019; 9:17. PMC: 6371545. DOI: 10.1186/s13578-019-0281-3. View

15.

Manochantr S, Marupanthorn K, Tantrawatpan C, Kheolamai P . The expression of neurogenic markers after neuronal induction of chorion-derived mesenchymal stromal cells. Neurol Res. 2015; 37(6):545-52. DOI: 10.1179/1743132815Y.0000000019. View

16.

Frohlich L . Micrornas at the Interface between Osteogenesis and Angiogenesis as Targets for Bone Regeneration. Cells. 2019; 8(2). PMC: 6406308. DOI: 10.3390/cells8020121. View

17.

Westhauser F, Karadjian M, Essers C, Senger A, Hagmann S, Schmidmaier G . Osteogenic differentiation of mesenchymal stem cells is enhanced in a 45S5-supplemented β-TCP composite scaffold: an in-vitro comparison of Vitoss and Vitoss BA. PLoS One. 2019; 14(2):e0212799. PMC: 6392320. DOI: 10.1371/journal.pone.0212799. View

18.

Marupanthorn K, Tantrawatpan C, Kheolamai P, Tantikanlayaporn D, Manochantr S . Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord. Int J Mol Med. 2017; 39(3):654-662. PMC: 5360390. DOI: 10.3892/ijmm.2017.2872. View

19.

Manochantr S, Marupanthorn K, Tantrawatpan C, Kheolamai P, Tantikanlayaporn D, Sanguanjit P . The Effects of BMP-2, miR-31, miR-106a, and miR-148a on Osteogenic Differentiation of MSCs Derived from Amnion in Comparison with MSCs Derived from the Bone Marrow. Stem Cells Int. 2018; 2017:7257628. PMC: 5733904. DOI: 10.1155/2017/7257628. View

20.

Stenderup K, Justesen J, Clausen C, Kassem M . Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003; 33(6):919-26. DOI: 10.1016/j.bone.2003.07.005. View